NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Elbasvir

Last Revision: February 7, 2019.

Estimated reading time: 1 minute

CASRN: 1370468-36-2

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Elbasvir has not been studied in nursing mothers being treated for hepatitis C infection. Because it is greater than 99.9% bound to maternal plasma proteins, amounts in breastmilk are likely to be very low. Some sources recommend against breastfeeding when elbasvir is used with ribavirin.

Hepatitis C is not transmitted through breastmilk[1][2] and breastmilk has been shown to inactivate hepatitis C virus (HCV).[3][4] However, the Centers for Disease Control recommends that mothers with HCV infection should consider abstaining from breastfeeding if their nipples are cracked or bleeding. It is not clear if this warning would apply to mothers who are being treated for hepatitis C.

Infants born to mothers with HCV infection should be tested for HCV infection; because maternal antibody is present for the first 18 months of life and before the infant mounts an immunologic response, nucleic acid testing is recommended.[1][2]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

(Hepatitis C) Interferon Alfa, Interferon Alfacon-1, Peginterferon Alfa

References

1.
Cottrell EB, Chou R, Wasson N et al. Reducing risk for mother-to-infant transmission of hepatitis C virus: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;158:109-13. [PubMed: 23437438]
2.
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137. [PMC free article: PMC5885289] [PubMed: 26042815]
3.
Pfaender S, Heyden J, Friesland M et al. Inactivation of hepatitis C virus infectivity by human breast milk. J Infect Dis. 2013;208:1943-52. [PubMed: 24068703]
4.
Tovo PA, Calitri C, Scolfaro C et al. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression. World J Gastroenterol. 2016;22:1382-92. [PMC free article: PMC4721973] [PubMed: 26819507]

Substance Identification

Substance Name

Elbasvir

CAS Registry Number

1370468-36-2

Drug Class

  • Breast Feeding
  • Antiviral Agents
  • NS5A Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Pibrentasvir[Drugs and Lactation Database (...]
    Review Pibrentasvir
    . Drugs and Lactation Database (LactMed). 2006
  • Review Daclatasvir[Drugs and Lactation Database (...]
    Review Daclatasvir
    . Drugs and Lactation Database (LactMed). 2006
  • Review Ombitasvir[Drugs and Lactation Database (...]
    Review Ombitasvir
    . Drugs and Lactation Database (LactMed). 2006
  • Review Ledipasvir[Drugs and Lactation Database (...]
    Review Ledipasvir
    . Drugs and Lactation Database (LactMed). 2006
  • Review Simeprevir[Drugs and Lactation Database (...]
    Review Simeprevir
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...